Peter Clark

Peter Clark is an Associate Professor in the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA). His work focuses on molecular pharmacology, cancer biology, and metabolic imaging using positron emission tomography (PET). He has secured significant NIH grants for non-invasive imaging of brain-infiltrating lymphocytes and imaging immune-mediated liver rejection.

• Research Interests:
  • Targeting glucose metabolism in cancer and autoimmune diseases
  • Development of PET tracers for immune activation and organ-specific imaging
  • Mechanisms of kinase inhibitors in disease models
  • Role of O-GlcNAc glycosylation in cellular processes
• Recent Trends:
  • 2024: Machine learning frameworks for protein docking and metabolic disease modeling
  • 2023: FLT3 inhibition in lung cancer glucose consumption
  • 2022: Deoxycytidine kinase as an autoimmune therapy target

Collaborations with experts in immunology, oncology, and neuroscience (e.g., David Nathanson, Owen Witte) and contributions to clinical genomics and pharmacogenomics.